NPD [China Nepstar Chain Drugstore] SC 13E3/A: China Nepstar Chain Drugstore Ltd. _______, 2016 Shareholders

[China Nepstar Chain Drugstore Ltd. _______, 2016 Shareholders of China Nepstar Chain Drugstore Ltd. Re: Notice of Extraordinary General Meeting of Shareholders You are cordially invited to attend an extraordinary general meeting of shareholders of China Nepstar Chain Drugstore Ltd. (the “Company”) to be held on ________, 2016 at ______ a.m. (Beijing Time). The meeting will be held at the] []

NPD [China Nepstar Chain Drugstore] 20-F: (Original Filing)

[CHINA NEPSTAR CHAIN DRUGSTORE LTD. ANNUAL REPORT ON FORM 20-F Table of Contents Page PART I ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS 2 ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE 2 ITEM 3. KEY INFORMATION 2 ITEM 4. INFORMATION ON THE COMPANY 31 ITEM 4A. UNRESOLVED STAFF COMMENTS 49] [ENTRUSTMENT LOAN AGREEMENT (this “Agreement”) (For Corporate Business) Tian An Serial No. : Xing Yin Shen Entrustor : Shenzhen Nepstar Pharmaceutical Co., Ltd. (affixed with the corporate seal) Domicile : Neptunus Yinhe Keji Building, Kejizhong 3rd Road, Shenzhen Legal Representative/Principal Officer : Zhang Yingnan Contact Person : ___________________ Title : _______________________ Mailing Address : Neptunus Yinhe Keji Building, Kejizhong 3rd] [ENTRUSTMENT LOAN AGREEMENT (this “Agreement”) (For Corporate Business) Tian An Serial No. : Xing Yin Shen Entrustor : Shenzhen Nepstar Pharmaceutical Co., Ltd. (affixed with the corporate seal) Domicile : Neptunus Yinhe Keji Building, Kejizhong 3rd Road, Shenzhen Legal Representative/Principal Officer : Zhang Yingnan Contact Person : Title : _______________________ Mailing Address : Neptunus Yinhe Keji Building, Kejizhong 3rd Road,] [SUBSIDIARIES OF THE COMPANY Wholly-owned subsidiaries, each of which is duly incorporated in the PRC: • Shenzhen Nepstar Pharmaceutical Electronic Technologies Ltd. • Shenzhen Nepstar Commerce Development Ltd. • Shenzhen Jinfu Logistics Service Co., Ltd. • Shenzhen Wisconsin Trading Development Co., Ltd. • Shenzhen Nepstar Pharmaceutical Co., Ltd. Consolidated entities, each of which is duly incorporated in the PRC: •] [Certification by the Chief Executive Officer Sarbanes-Oxley Act of 2002 I, Yingnan (Rebecca) Zhang, certify that: 1. I have reviewed this annual report on Form 20-F of China Nepstar Chain Drugstore Ltd.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the] [Certification by the Chief Financial Officer Sarbanes-Oxley Act of 2002 I, Zixin Shao, certify that: 1. I have reviewed this annual report on Form 20-F of China Nepstar Chain Drugstore Ltd.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements] [Certification by the Chief Executive Officer Sarbanes-Oxley Act of 2002 1. 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Yingnan (Rebecca) Zhang Chief Executive Officer] [Certification by the Chief Financial Officer Sarbanes-Oxley Act of 2002 1. 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Zixin Shao Chief Financial Officer] [Consent of Independent Registered Public Accounting Firm To the Board of Directors China Nepstar Chain Drugstore Ltd.: We consent to the incorporation by reference in the registration statement (No. 333-147702) on Form S-8 of China Nepstar Chain Drugstore Ltd. of our report dated April 26, 2016, with respect to the consolidated balance sheets of China Nepstar Chain Drugstore Ltd. and] [April 26, 2016 China Nepstar Chain Drugstore Ltd. 25F, Neptunus Yinhe Keji Building No.1, Kejizhong 3rd Road Nanshan District, Shenzhen Guangdong Province 518057 People’s Republic of China Dear Sir/Madam: Annual Report SEC We hereby consent to the reference of our name and inclusion of the summary and quotation of our opinion under the headings “ITEM 1A. RISK FACTORS” and “ITEM]

NPD [China Nepstar Chain Drugstore] 20-F: CHINA NEPSTAR CHAIN DRUGSTORE LTD. ANNUAL REPORT ON

[CHINA NEPSTAR CHAIN DRUGSTORE LTD. ANNUAL REPORT ON FORM 20-F Table of Contents Page PART I ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS 2 ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE 2 ITEM 3. KEY INFORMATION 2 ITEM 4. INFORMATION ON THE COMPANY 31 ITEM 4A. UNRESOLVED STAFF COMMENTS 49] [ENTRUSTMENT LOAN AGREEMENT (this “Agreement”) (For Corporate Business) Tian An Serial No. : Xing Yin Shen Entrustor : Shenzhen Nepstar Pharmaceutical Co., Ltd. (affixed with the corporate seal) Domicile : Neptunus Yinhe Keji Building, Kejizhong 3rd Road, Shenzhen Legal Representative/Principal Officer : Zhang Yingnan Contact Person : ___________________ Title : _______________________ Mailing Address : Neptunus Yinhe Keji Building, Kejizhong 3rd] [ENTRUSTMENT LOAN AGREEMENT (this “Agreement”) (For Corporate Business) Tian An Serial No. : Xing Yin Shen Entrustor : Shenzhen Nepstar Pharmaceutical Co., Ltd. (affixed with the corporate seal) Domicile : Neptunus Yinhe Keji Building, Kejizhong 3rd Road, Shenzhen Legal Representative/Principal Officer : Zhang Yingnan Contact Person : Title : _______________________ Mailing Address : Neptunus Yinhe Keji Building, Kejizhong 3rd Road,] [SUBSIDIARIES OF THE COMPANY Wholly-owned subsidiaries, each of which is duly incorporated in the PRC: • Shenzhen Nepstar Pharmaceutical Electronic Technologies Ltd. • Shenzhen Nepstar Commerce Development Ltd. • Shenzhen Jinfu Logistics Service Co., Ltd. • Shenzhen Wisconsin Trading Development Co., Ltd. • Shenzhen Nepstar Pharmaceutical Co., Ltd. Consolidated entities, each of which is duly incorporated in the PRC: •] [Certification by the Chief Executive Officer Sarbanes-Oxley Act of 2002 I, Yingnan (Rebecca) Zhang, certify that: 1. I have reviewed this annual report on Form 20-F of China Nepstar Chain Drugstore Ltd.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the] [Certification by the Chief Financial Officer Sarbanes-Oxley Act of 2002 I, Zixin Shao, certify that: 1. I have reviewed this annual report on Form 20-F of China Nepstar Chain Drugstore Ltd.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements] [Certification by the Chief Executive Officer Sarbanes-Oxley Act of 2002 1. 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Yingnan (Rebecca) Zhang Chief Executive Officer] [Certification by the Chief Financial Officer Sarbanes-Oxley Act of 2002 1. 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Zixin Shao Chief Financial Officer] [Consent of Independent Registered Public Accounting Firm To the Board of Directors China Nepstar Chain Drugstore Ltd.: We consent to the incorporation by reference in the registration statement (No. 333-147702) on Form S-8 of China Nepstar Chain Drugstore Ltd. of our report dated April 26, 2016, with respect to the consolidated balance sheets of China Nepstar Chain Drugstore Ltd. and] [April 26, 2016 China Nepstar Chain Drugstore Ltd. 25F, Neptunus Yinhe Keji Building No.1, Kejizhong 3rd Road Nanshan District, Shenzhen Guangdong Province 518057 People’s Republic of China Dear Sir/Madam: Annual Report SEC We hereby consent to the reference of our name and inclusion of the summary and quotation of our opinion under the headings “ITEM 1A. RISK FACTORS” and “ITEM]

NPD [China Nepstar Chain Drugstore] SC 13E3/A: (Original Filing)

[China Nepstar Chain Drugstore Ltd. _______, 2016 Shareholders of China Nepstar Chain Drugstore Ltd. Re: Notice of Extraordinary General Meeting of Shareholders You are cordially invited to attend an extraordinary general meeting of shareholders of China Nepstar Chain Drugstore Ltd. (the “Company”) to be held on ________, 2016 at ______ a.m. (Beijing Time). The meeting will be held at the] []

NPD [China Nepstar Chain Drugstore] SC 13E3/A: China Nepstar Chain Drugstore Ltd. _______, 2016 Shareholders

[China Nepstar Chain Drugstore Ltd. _______, 2016 Shareholders of China Nepstar Chain Drugstore Ltd. Re: Notice of Extraordinary General Meeting of Shareholders You are cordially invited to attend an extraordinary general meeting of shareholders of China Nepstar Chain Drugstore Ltd. (the “Company”) to be held on ________, 2016 at ______ a.m. (Beijing Time). The meeting will be held at the] []

NPD [China Nepstar Chain Drugstore] SC 13E3: China Nepstar Chain Drugstore Ltd. _______, 2016 Shareholders

[China Nepstar Chain Drugstore Ltd. _______, 2016 Shareholders of China Nepstar Chain Drugstore Ltd. Re: Notice of Extraordinary General Meeting of Shareholders You are cordially invited to attend an extraordinary general meeting of shareholders of China Nepstar Chain Drugstore Ltd. (the “Company”) to be held on ________, 2016 at ______ a.m. (Beijing Time). The meeting will be held at the] [Commitment Letter STRICTLY Private and confidential CHINA NEPTUNUS DRUGSTORE HOLDING LTD. 25F, Neptunus Yinhe Keji Building Attention: Simin Zhang March 16, 2016 Dear Sirs: you Borrower we us Bank Merger Target CHINA NEPTUNUS DRUGSTORE HOLDING LTD. (“ Facility Transactions In connection with the Merger, we understand that you wish to obtain a senior secured term loan facility (the “ This] [Draft – for discussion only CORPORATE FINANCE FINANCIAL ADVISORY SERVICES FINANCIAL RESTRUCTURING STRATEGIC CONSULTING HL.com Project Lily Preliminary Draft – Discussion Material September 7, 2015 华利安 Confidential Draft – for discussion only Transaction Value Overview Project Lily 1 Source: Company filings; LTM financial per Company filings, NFY and NFY+1 financials per Company management Notes: 1. Based on 98,723,470 outstanding ADS] [CORPORATE FINANCE FINANCIAL ADVISORY SERVICES FINANCIAL RESTRUCTURING STRATEGIC CONSULTING HL.com China Nepstar Chain Drugstore Ltd. Presentation to the Special Committee March 16, 2016 Confidential DRAFT Table of Contents Page Transaction Overview 2 Financial Analysis 9 Appendices 16 Additional Financial Data 17 Disclaimer 25 1 China Nepstar Chain Drugstore Ltd. Transaction Overview DRAFT ADS H older Structure Transaction Overview 4 Ownership] []

NPD [China Nepstar Chain Drugstore] SC 13E3: (Original Filing)

[China Nepstar Chain Drugstore Ltd. _______, 2016 Shareholders of China Nepstar Chain Drugstore Ltd. Re: Notice of Extraordinary General Meeting of Shareholders You are cordially invited to attend an extraordinary general meeting of shareholders of China Nepstar Chain Drugstore Ltd. (the “Company”) to be held on ________, 2016 at ______ a.m. (Beijing Time). The meeting will be held at the] [Commitment Letter STRICTLY Private and confidential CHINA NEPTUNUS DRUGSTORE HOLDING LTD. 25F, Neptunus Yinhe Keji Building Attention: Simin Zhang March 16, 2016 Dear Sirs: you Borrower we us Bank Merger Target CHINA NEPTUNUS DRUGSTORE HOLDING LTD. (“ Facility Transactions In connection with the Merger, we understand that you wish to obtain a senior secured term loan facility (the “ This] [Draft – for discussion only CORPORATE FINANCE FINANCIAL ADVISORY SERVICES FINANCIAL RESTRUCTURING STRATEGIC CONSULTING HL.com Project Lily Preliminary Draft – Discussion Material September 7, 2015 华利安 Confidential Draft – for discussion only Transaction Value Overview Project Lily 1 Source: Company filings; LTM financial per Company filings, NFY and NFY+1 financials per Company management Notes: 1. Based on 98,723,470 outstanding ADS] [CORPORATE FINANCE FINANCIAL ADVISORY SERVICES FINANCIAL RESTRUCTURING STRATEGIC CONSULTING HL.com China Nepstar Chain Drugstore Ltd. Presentation to the Special Committee March 16, 2016 Confidential DRAFT Table of Contents Page Transaction Overview 2 Financial Analysis 9 Appendices 16 Additional Financial Data 17 Disclaimer 25 1 China Nepstar Chain Drugstore Ltd. Transaction Overview DRAFT ADS H older Structure Transaction Overview 4 Ownership] []

NPD [China Nepstar Chain Drugstore] 6-K: (Original Filing)

[China Nepstar Chain Drugstore Ltd. Reports Fourth Quarter and Fiscal Year 2015 Financial Results SHENZHEN, China, March 29, 2015 -- China Nepstar Chain Drugstore Ltd. (NYSE: NPD) ("Nepstar" or the "Company"), a leading retail drugstore chain in China based on the number of directly operated stores, today announced its unaudited financial results for the fourth quarter and fiscal year ended] [FORM 6-K Commission Filing Number: 001-33751 CHINA NEPSTAR CHAIN DRUGSTORE LTD. 25F, Neptunus Yinhe Keji Building No.1, Kejizhong 3rd Road, Nanshan District Shenzhen, Guangdong Province 518057 People’s Republic of China x ¨ Form 20-F ¨ x Yes ¨ x Yes Number Description of Document 99.1 Press Release CHINA NEPSTAR CHAIN DRUGSTORE LTD.]

NPD [China Nepstar Chain Drugstore] 6-K: China Nepstar Chain Drugstore Ltd. Reports Fourth Quarter

[China Nepstar Chain Drugstore Ltd. Reports Fourth Quarter and Fiscal Year 2015 Financial Results SHENZHEN, China, March 29, 2015 -- China Nepstar Chain Drugstore Ltd. (NYSE: NPD) ("Nepstar" or the "Company"), a leading retail drugstore chain in China based on the number of directly operated stores, today announced its unaudited financial results for the fourth quarter and fiscal year ended] [FORM 6-K Commission Filing Number: 001-33751 CHINA NEPSTAR CHAIN DRUGSTORE LTD. 25F, Neptunus Yinhe Keji Building No.1, Kejizhong 3rd Road, Nanshan District Shenzhen, Guangdong Province 518057 People’s Republic of China x ¨ Form 20-F ¨ x Yes ¨ x Yes Number Description of Document 99.1 Press Release CHINA NEPSTAR CHAIN DRUGSTORE LTD.]

By | 2016-03-30T08:21:00+00:00 March 29th, 2016|Categories: Chinese Stocks, NPD, Webplus ver|Tags: , , , , , |0 Comments

NPD [China Nepstar Chain Drugstore] SC 13D: (Original Filing)

[Commitment Letter STRICTLY Private and confidential CHINA NEPTUNUS DRUGSTORE HOLDING LTD. 25F, Neptunus Yinhe Keji Building Attention: Simin Zhang March 16, 2016 Dear Sirs: you Borrower we us Bank Merger Target CHINA NEPTUNUS DRUGSTORE HOLDING LTD. (“ Facility Transactions In connection with the Merger, we understand that you wish to obtain a senior secured term loan facility (the “ This] [(1) This CUSIP number applies to the Issuer’s American Depositary Shares, each representing two Ordinary Shares. 1. Name of Reporting Person Simin Zhang 2. Check the Appropriate Box if A Member of A Group (a) ☐ (b) 3. SEC Use Only 4. Source of Funds PF and BK 5 6. Citizenship or Place of Organization People’s Republic of China Number]

Skip to toolbar